These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20155316

  • 21. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
    Jiang MC, Luo SF, Li LT, Lin CC, Du SY, Lin CY, Hsu YW, Liao CF.
    J Exp Clin Cancer Res; 2007 Mar; 26(1):91-9. PubMed ID: 17550137
    [Abstract] [Full Text] [Related]

  • 22. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.
    Vasey PA, Jones NA, Jenkins S, Dive C, Brown R.
    Mol Pharmacol; 1996 Dec; 50(6):1536-40. PubMed ID: 8967975
    [Abstract] [Full Text] [Related]

  • 23. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Lee KW, Jeong JY, Lim BJ, Chang YK, Lee SJ, Na KR, Shin YT, Choi DE.
    Toxicology; 2009 Mar 29; 257(3):137-43. PubMed ID: 19152827
    [Abstract] [Full Text] [Related]

  • 24. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ, Liu ZJ, Shimoi K, Zhu BT.
    Cancer Res; 2005 Jan 15; 65(2):387-93. PubMed ID: 15695378
    [Abstract] [Full Text] [Related]

  • 25. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
    Hattangadi DK, DeMasters GA, Walker TD, Jones KR, Di X, Newsham IF, Gewirtz DA.
    Biochem Pharmacol; 2004 Nov 01; 68(9):1699-708. PubMed ID: 15450935
    [Abstract] [Full Text] [Related]

  • 26. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA, Lupu R.
    Int J Mol Med; 2005 Jan 01; 15(1):33-40. PubMed ID: 15583825
    [Abstract] [Full Text] [Related]

  • 27. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
    Jiang PD, Zhao YL, Deng XQ, Mao YQ, Shi W, Tang QQ, Li ZG, Zheng YZ, Yang SY, Wei YQ.
    Biomed Pharmacother; 2010 Nov 01; 64(9):609-14. PubMed ID: 20888174
    [Abstract] [Full Text] [Related]

  • 28. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 29. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
    Fan S, Cherney B, Reinhold W, Rucker K, O'Connor PM.
    Clin Cancer Res; 1998 Apr 01; 4(4):1047-54. PubMed ID: 9563901
    [Abstract] [Full Text] [Related]

  • 30. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K, Kaminski R, Legat M, Kopec M, Nowis D, Skierski JS, Koronkiewicz M, Jakóbisiak M, Golab J.
    Int J Oncol; 2004 May 01; 24(5):1149-57. PubMed ID: 15067336
    [Abstract] [Full Text] [Related]

  • 31. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
    Thai le M, Labrinidis A, Hay S, Liapis V, Bouralexis S, Welldon K, Coventry BJ, Findlay DM, Evdokiou A.
    Cancer Res; 2006 May 15; 66(10):5363-70. PubMed ID: 16707463
    [Abstract] [Full Text] [Related]

  • 32. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
    Crawford KW, Bowen WD.
    Cancer Res; 2002 Jan 01; 62(1):313-22. PubMed ID: 11782394
    [Abstract] [Full Text] [Related]

  • 33. Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines.
    Aunoble B, Bernard-Gallon D, Bignon YJ.
    Oncol Rep; 2001 Jan 01; 8(3):663-8. PubMed ID: 11295099
    [Abstract] [Full Text] [Related]

  • 34. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
    Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ, O'Connor PM.
    Cancer Res; 1995 Apr 15; 55(8):1649-54. PubMed ID: 7712469
    [Abstract] [Full Text] [Related]

  • 35. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
    Thomadaki H, Scorilas A.
    Biol Chem; 2008 Nov 15; 389(11):1427-34. PubMed ID: 18783338
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 39. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
    Ruiz-Ruiz C, Muñoz-Pinedo C, López-Rivas A.
    Cancer Res; 2000 Oct 15; 60(20):5673-80. PubMed ID: 11059759
    [Abstract] [Full Text] [Related]

  • 40. Sildenafil, a selective phosphodiesterase type 5 inhibitor, enhances memory reconsolidation of an inhibitory avoidance task in mice.
    Boccia MM, Blake MG, Krawczyk MC, Baratti CM.
    Behav Brain Res; 2011 Jul 07; 220(2):319-24. PubMed ID: 21333692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.